Company intelligence
Clyra
Decision intelligence for oncology drug development.
Biotechnology Research
San Francisco, US
3 employees
1 public signals
About Clyra
Clyra is building the decision-making platform for oncology drug development. We help biopharma teams define the right patients and biomarker strategy before a trial, then identify response and resistance biomarkers to guide the next phase of development. Clyra combines human cancer data with longitudinal molecular, treatment, and outcome data from naturally occurring canine cancers. We’re starting with osteosarcoma and expanding into other rare and hard-to-model cancers.
Verified activity
Signals from Clyra
1 published signal